Delivery Order SPE2DB22D2214-SPE2DB25FS6DN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,418.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,361.69 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order, awarded on July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $3,515.79 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $6,861.83. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by August 14, 2025,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,380.41 delivery order on August 1, 2025, for the supply of Lidocaine 5% Patch 30s, with completion targeted for August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units with a ceiling value of $3,038.31. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $8,508.28 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office is located in Conshohocken,...
- The Defense Logistics Agency awarded a $10,616.14 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lidocaine 5% patches (30-count units). This is a firm fixed-price, non-set-aside contract with performance to be completed by August 1, 2025, and fulfillment occurring at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lidocaine 5% patches in a quantity of 30 units, with a ceiling value of $2,722.08. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6DNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,297.25 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lidocaine 5% Patch 30s. This competitively awarded contract, utilizing firm fixed pricing with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its $999,999,999.00 prime IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026. This comprehensive contract vehicle enables the company to supply an extensive range of pharmaceutical products and medical commodities supporting military healthcare systems globally. The current delivery order for Lidocaine patches aligns with AmerisourceBergen's established role in fulfilling pain management pharmaceutical needs for the Defense Health Agency and other government healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/14/25 |